Quick Takeaways
- This page summarizes PATRICK DEVAL L's Form 4 filing for Cerevel Therapeutics Holdings, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 16 Jun 2022, 16:46.
PATRICK DEVAL L - 14 Jun 2022 Form 4 Insider Report for Cerevel Therapeutics Holdings, Inc.
- Role
- Director
- Signature
- /s/ Mark Bodenrader, as Attorney-in-Fact
- Issuer symbol
- N/A
- Transactions as of
- 14 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 16 Jun 2022, 16:46:00 UTC
- Previous filing
- 15 Jun 2022
- Next filing
- 17 Jun 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"PATRICK DEVAL L filed Form 4 for Cerevel Therapeutics Holdings, Inc. on 16 Jun 2022."
What Changed
- Previous filing in this sequence was filed on 15 Jun 2022.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CERE | Stock Option (Right to Buy) | Award | $0 | +23,459 | $0.000000 | 23,459 | 14 Jun 2022 | Common Stock | 23,459 | $24.35 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one-year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date. |
Remarks:
Exhibit 24 - Power of Attorney